Refueling Innovation Engine Vaccines

McKinsey
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

40
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
frame_problem
03
The slide uses a hub-and-spoke diagram to illustrate the firm's central position in the vaccine industry network.establish_context
04
frame_problem
Open slide detailBeat · Problem
05
The slide uses a combination of bar charts and a central column of circular indicators to visualize the data.analyze_data
Open slide detailBeat · Problem
06
present_solution
Open slide detailBeat · Problem
07
The slide uses a custom icon-based legend (circles with varying fill levels) to represent the 'Improvement opportunities' intensity.frame_problem
Open slide detailBeat · Problem
08
The slide uses a split-screen approach to contrast pediatric complexity vs adult low-uptake.frame_problem
Open slide detailBeat · Problem
09
frame_problem
Open slide detailBeat · Problem
10
McKinsey & Company branding present.transition
Open slide detailBeat · Agitate
11
The chart uses a combination of bar chart and trend line with growth rate annotations.summarize
Open slide detailBeat · Agitate
12
The chart highlights a shift in the proportion of PII candidates between 2005 and 2015 using callout arrows.analyze_data
Open slide detailBeat · Agitate
13
The table and charts show a clear trend of increasing blockbuster vaccine products despite a decrease in total launches.analyze_data
Open slide detailBeat · Agitate
14
The chart uses a broken axis between 2015 and 2020.analyze_data
Open slide detailBeat · Agitate
15
The chart uses a grouped bar chart format to compare two categories (Vx and Rx) over time. The source is Evaluate Pharma, February 2016.analyze_data
Open slide detailBeat · Agitate
16
transition
Open slide detailBeat · Agitate
17
The chart highlights a -21% delta between the contribution of new launches in 2011 vs 2015.analyze_data
Open slide detailBeat · Agitate
18
The slide highlights the shift in R&D activity towards smaller players and emerging markets.analyze_data
Open slide detailBeat · Agitate
19
The slide uses a bar chart to compare attrition rates and a list of specific industry examples to illustrate the point.diagnose
Open slide detailBeat · Agitate
20
transition
Open slide detailBeat · Agitate
21
The slide uses three separate line charts to illustrate the divergence in profitability trends between vaccine divisions and other pharma/OTC divisions.analyze_data
22
The slide uses a bar chart to illustrate the convergence of success rates between vaccines and biologics, supporting the argument that vaccines are becoming lesanalyze_data
24
The slide highlights a 27% increase in time to market between 2003-08 and 2009-14.diagnose
Open slide detailLoop · Cost Of Inaction
25
The slide uses a list format to present case examples of operational risks.cite_precedent
Open slide detailLoop · Cost Of Inaction
26
The slide uses a side-by-side comparison structure to define evaluation criteria for vaccine development.present_framework
Open slide detailLoop · Cost Of Inaction
27
The slide uses a 2x2 matrix to illustrate the shift in innovation difficulty. The top-right quadrant is highlighted with a checkmark to represent past successespresent_framework
Open slide detailLoop · Cost Of Inaction
28
The slide uses a numbered list format to define archetypes.present_framework
29
transition
Open slide detailBeat · Solution
30
The slide uses a numbered list format to align specific strategic interventions with market segments (High income/nosocomial, Incremental improvements, Emergingpresent_solution
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
31
The slide uses a numbered list format to map specific strategic interventions to five distinct categories.present_solution
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
32
transition
33
analyze_data
34
frame_problem
35
analyze_data
36
analyze_data
37
The table contains a likely typo in the row labels (PII appears twice) and the notes below the table reference drops that do not align with the provided data vaanalyze_data
38
The table tracks sales figures and annual growth rates (p.a) across specific time intervals, with qualitative commentary on growth drivers.analyze_data
39
The table tracks two categories: New launches and Existing vaccines over a 20-year period.analyze_data
40
analyze_data